4.6 Letter

Intratumor BRAFV600E Heterogeneity and Kinase Inhibitors in the Treatment of Thyroid Cancer: A Call for Participation

Journal

THYROID
Volume 23, Issue 4, Pages 517-519

Publisher

MARY ANN LIEBERT, INC
DOI: 10.1089/thy.2012.0614

Keywords

-

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available